Synopsis
Synopsis
0
KDMF
0
VMF
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Amdinocillin Pivoxil
2. Fl 1039
3. Fl-1039
4. Fl1039
5. Hydrochloride, Pivmecillinam
6. Mecillinam Pivaloyl Ester
7. Pivaloyl Ester, Mecillinam
8. Pivamdinocillin
9. Pivmecillinam Hydrochloride
10. Pivoxil, Amdinocillin
11. Selexid
1. Amdinocillin Pivoxil
2. 32886-97-8
3. Pivmecilinamo
4. Pivmecillinamum
5. Selexid
6. Amdinocillin Pivoxil [usan]
7. Pivmecilinamo [inn-spanish]
8. Pivmecillinamum [inn-latin]
9. Ro 10-9071
10. Amdinocillin, Pivaloyloxymethyl Ester
11. Pivmecillinam (inn)
12. Pivmecillinam [inn]
13. 1wam1oq30b
14. Amdinocillin Pivoxil (usan)
15. Ro-10-9071
16. Chebi:51210
17. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(((hexahydro-1h-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl Ester, (2s-(2alpha,5alpha,6beta))-
18. Hydroxymethyl (2s,5r,6r)-6-(((hexahydro-1h-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate Pivalate (ester)
19. Coactabs
20. [(2,2-dimethylpropanoyl)oxy]methyl (2s,5r,6r)-6-[(azepan-1-ylmethylidene)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
21. [(2,2-dimethylpropanoyl)oxy]methyl 6beta-[(azepan-1-ylmethylidene)amino]-2,2-dimethylpenam-3alpha-carboxylate
22. Coactabs (tn)
23. 2,2-dimethylpropanoyloxymethyl (2s,5r,6r)-6-(azepan-1-ylmethylideneamino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
24. Ncgc00016813-01
25. Cas-32887-03-9
26. Unii-1wam1oq30b
27. Sr-01000838842
28. Einecs 251-276-6
29. Prestwick0_001053
30. Prestwick1_001053
31. Prestwick2_001053
32. Prestwick3_001053
33. Pivmecillinam [jan]
34. Schembl33907
35. Schembl33908
36. Bspbio_001006
37. Pivmecillinam [mart.]
38. Spbio_002933
39. Pivmecillinam [who-dd]
40. Bpbio1_001108
41. Chembl1525183
42. Chembl1616433
43. Chembl1650818
44. Dtxsid7048538
45. Gtpl10922
46. Amdinocillin Pivoxil [mi]
47. Pivmecillinam, >=98% (hplc)
48. Bcp07843
49. Hy-b0810
50. Zinc4214799
51. Zinc13704173
52. Db01605
53. Ro-109071
54. Ncgc00179344-01
55. Ncgc00179344-04
56. Ncgc00179344-07
57. Ab00514713
58. D02889
59. A918810
60. Q418086
61. Sr-01000838842-2
62. Brd-k67100011-003-03-0
63. (2s,6r)-pivaloyloxymethyl 6-((e)-azepan-1-ylmethyleneamino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
64. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(((hexahydro-1h-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl Ester, (2s-(2.alpha.,5.alpha.,6.beta.))-
Molecular Weight | 439.6 g/mol |
---|---|
Molecular Formula | C21H33N3O5S |
XLogP3 | 3.1 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 8 |
Exact Mass | 439.21409234 g/mol |
Monoisotopic Mass | 439.21409234 g/mol |
Topological Polar Surface Area | 114 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 710 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Used to treat infections due to mecillinam-sensitive organisms such as urinary tract infections, salmonellosis and typhoid fever.
Pivmecillinam is a pivaloyloxymethyl ester of amdinocillin that is well absorbed orally, but broken down to amdinocillin in the intestinal mucosa. It is active against gram-negative organisms and used as for amdinocillin.
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Anti-Infective Agents, Urinary
Substances capable of killing agents causing urinary tract infections or of preventing them from spreading. (See all compounds classified as Anti-Infective Agents, Urinary.)
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01C - Beta-lactam antibacterials, penicillins
J01CA - Penicillins with extended spectrum
J01CA08 - Pivmecillinam
Absorption
Well absorbed following oral administration.
Pivmecillinam interferes with the biosynthesis of the bacterial cell wall however its activity is slightly different from that of other penicillins and cephalosporins
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Pivmecillinam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pivmecillinam, including repackagers and relabelers. The FDA regulates Pivmecillinam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pivmecillinam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pivmecillinam manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pivmecillinam supplier is an individual or a company that provides Pivmecillinam active pharmaceutical ingredient (API) or Pivmecillinam finished formulations upon request. The Pivmecillinam suppliers may include Pivmecillinam API manufacturers, exporters, distributors and traders.
click here to find a list of Pivmecillinam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Pivmecillinam DMF (Drug Master File) is a document detailing the whole manufacturing process of Pivmecillinam active pharmaceutical ingredient (API) in detail. Different forms of Pivmecillinam DMFs exist exist since differing nations have different regulations, such as Pivmecillinam USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Pivmecillinam DMF submitted to regulatory agencies in the US is known as a USDMF. Pivmecillinam USDMF includes data on Pivmecillinam's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Pivmecillinam USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Pivmecillinam suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Pivmecillinam Drug Master File in Japan (Pivmecillinam JDMF) empowers Pivmecillinam API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Pivmecillinam JDMF during the approval evaluation for pharmaceutical products. At the time of Pivmecillinam JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Pivmecillinam suppliers with JDMF on PharmaCompass.
A Pivmecillinam CEP of the European Pharmacopoeia monograph is often referred to as a Pivmecillinam Certificate of Suitability (COS). The purpose of a Pivmecillinam CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Pivmecillinam EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Pivmecillinam to their clients by showing that a Pivmecillinam CEP has been issued for it. The manufacturer submits a Pivmecillinam CEP (COS) as part of the market authorization procedure, and it takes on the role of a Pivmecillinam CEP holder for the record. Additionally, the data presented in the Pivmecillinam CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Pivmecillinam DMF.
A Pivmecillinam CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Pivmecillinam CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Pivmecillinam suppliers with CEP (COS) on PharmaCompass.
A Pivmecillinam written confirmation (Pivmecillinam WC) is an official document issued by a regulatory agency to a Pivmecillinam manufacturer, verifying that the manufacturing facility of a Pivmecillinam active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Pivmecillinam APIs or Pivmecillinam finished pharmaceutical products to another nation, regulatory agencies frequently require a Pivmecillinam WC (written confirmation) as part of the regulatory process.
click here to find a list of Pivmecillinam suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pivmecillinam as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Pivmecillinam API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Pivmecillinam as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Pivmecillinam and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pivmecillinam NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Pivmecillinam suppliers with NDC on PharmaCompass.
Pivmecillinam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pivmecillinam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pivmecillinam GMP manufacturer or Pivmecillinam GMP API supplier for your needs.
A Pivmecillinam CoA (Certificate of Analysis) is a formal document that attests to Pivmecillinam's compliance with Pivmecillinam specifications and serves as a tool for batch-level quality control.
Pivmecillinam CoA mostly includes findings from lab analyses of a specific batch. For each Pivmecillinam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pivmecillinam may be tested according to a variety of international standards, such as European Pharmacopoeia (Pivmecillinam EP), Pivmecillinam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pivmecillinam USP).
LOOKING FOR A SUPPLIER?